Tag | Content |
---|
EnhancerAtlas ID | HS105-77649 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr8:41996960-41998850 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
RFX1 | MA0509.2 | chr8:41997879-41997895 | CGTCACCATGGCAACC | + | 7.02 | RFX1 | MA0509.2 | chr8:41997879-41997895 | CGTCACCATGGCAACC | - | 7.02 | RFX2 | MA0600.2 | chr8:41997879-41997895 | CGTCACCATGGCAACC | + | 7.04 | RFX2 | MA0600.2 | chr8:41997879-41997895 | CGTCACCATGGCAACC | - | 7.28 | RFX5 | MA0510.2 | chr8:41997879-41997895 | CGTCACCATGGCAACC | - | 7.02 | RFX5 | MA0510.2 | chr8:41997879-41997895 | CGTCACCATGGCAACC | + | 7 |
|
| Number of super-enhancer constituents: 22 | ID | Coordinate | Tissue/cell |
SE_10617 | chr8:41996742-42000638 | CD19_Primary | SE_11527 | chr8:41996399-42001420 | CD20 | SE_11958 | chr8:41996681-42001675 | CD3 | SE_12998 | chr8:41996662-42001195 | CD34_Primary_RO01480 | SE_13586 | chr8:41996283-42002252 | CD34_Primary_RO01536 | SE_14125 | chr8:41996516-42001382 | CD34_Primary_RO01549 | SE_14499 | chr8:41996655-42002299 | CD4_Memory_Primary_7pool | SE_15439 | chr8:41996577-42001146 | CD4_Memory_Primary_8pool | SE_15838 | chr8:41996734-42001407 | CD4_Naive_Primary_7pool | SE_16334 | chr8:41996804-42001135 | CD4_Naive_Primary_8pool | SE_16963 | chr8:41996692-42001266 | CD4p_CD225int_CD127p_Tmem | SE_17422 | chr8:41996437-42002582 | CD4p_CD25-_CD45RAp_Naive | SE_17925 | chr8:41996376-42001954 | CD4p_CD25-_CD45ROp_Memory | SE_18335 | chr8:41996168-42006983 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19215 | chr8:41996645-42001482 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_20189 | chr8:41996609-42001489 | CD56 | SE_20868 | chr8:41996560-42001475 | CD8_Memory_7pool | SE_21518 | chr8:41996610-42001381 | CD8_Naive_7pool | SE_22029 | chr8:41996575-42001644 | CD8_Naive_8pool | SE_22476 | chr8:41996473-42002144 | CD8_primiary | SE_38500 | chr8:41996634-42001102 | HUVEC | SE_62846 | chr8:41996602-42040825 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | ACATCTCATT AGACAGTGTT CAAGCAAATG CAACTTTATT TCAAAGTTCT TTTTTCTTTA 60 CAGGTAAAGA CATAGTATAA ACGGCAAAAT TCAAAAGGTG CAGAAGATTC TAGTACGGTG 120 AAAAGCAAGT TTTCTTTCTC TCCTCCACTC CTAGTCCCAC AGTGACCATC CTAAGAAGCA 180 ACCACTTCCA GAGATGCAAA CACACATACC ACATACACAC AGCCCTACTC ACACTCTTCT 240 GCACTTTATT ACTTAGAATA CACCGGAAAA TTTCCACGTC TCAGCAAATA CAGCTGCCCT 300 GTACTCTTTA ATGGCAGCTT AGTGTTCCCT CAGAGGGATG CGCCCCATAT CATTCACCCA 360 GCCCCCAGGG ACGGGCTTTT AGGTTGTTTC CAGCTGCTTG CTCTTACAAG CAACATTGCA 420 ACGCTGCCCT GTTACTTTTA ATCTTCTTTA TCCTGTGATT CCGTTCTGCT TTTCCTTCCA 480 GCACGACTGC AAAGTGACTG CGGGGTTTTC CCGAGTGCCC TCGCCCCAGA CCTCAGCGAG 540 TTATTTGTGG AGTCACCGGG TCCTGCTCCG CATTGTTATT CGAAGTCTCC CCGGGACAGC 600 GGGGAGCAGG CGGAGCTGCG TGTCCCGGCC TGCGCGTCTG GGCCCAGGCG GGCGCGCGTC 660 GCGCTCGGAT TTCGGGCGGA TAGTGCGTGG GAGGCGGCGC TGCCCTCCGT ATGCAGCGCG 720 CGTGCAGCCA AGGCGGCGCT GCGATCTGCG GCCTGGGGCC CTGGTGTGAA ACTCCCGCGG 780 AGACGCTCCC AGCCCCGGGC CGCAGCTCGC CCCTGCACGG AGGGAGGTGT CTAAAGGTGT 840 CTCTTAGGAA CAGGCACAAC CCGAGCAGCC GGGCCCCAGA ACAATGGGTG CTTTCAGCCG 900 CCCCTTTAGA TGCCTGGCCC GTCACCATGG CAACCACCCC ATTATTGAAA GTCAGTGCCG 960 GTCCCCGCCT TAGACGCTCT CCTCCCGGGC TCCCCTCCCC CGCCGGCCCC GCCGTATGGT 1020 GTGTGTGTCA CTGGCAGCTG TTGTCAAAAG AAGGCACCTC TTTGTCTCCA GGGGATGAAA 1080 GCCATTTGGT TTCCAGCGCC ACCCTTTCTC TCCGCCCGGC AACTTTTCTC CGCGTCCCGT 1140 CCCCAAGGCG TCCCTGGATG CGCGCGCTCG GCCCCGCGCC CGCCACCCGC GCTGAGTGCT 1200 GGTATCCTCC CCATCACTCA GCCCAGAGCC GTTCTGCCTC TGCCTCAAAC TCTCAGAGTC 1260 CTTATAAGTC TTATTCTCAA GAGTTGTGTC CCAGCGAAGG GAATCCGCCT TGGAAATCGC 1320 GGCTTCCTCC TTGCACGCCG CTCGCTGTTT CAGCGCAAGC CGGATCTCCC CTCACACCCA 1380 ACAGCACCAC CTTCCGAGAC TAGCGGCTCA TTACCGCCCA GTCCCCGCGG CCGGCGCAAG 1440 AACTCCTCGC CGGGCCCCAT TCCAGGCTGG GTCGGGTCTT TAGAATAAGG ACCAGTTGTG 1500 TGTCTCCCTG TCGCTGGCAG CGGATCACTT TCTGGCTGAA GAAAAGACAA AACGACGAGG 1560 GAAACAATAG GACCTGTATG TTTTACACAC AGTTCTCATT CGAAATGTAT CATGATCATA 1620 TTTTTAAAGA TGCGTGTTAC CTTTCATAAA TACCTAAATA AAACTTACTT TCTGTTGTCT 1680 GCGGAGGAAC TTGATAAACA TTAAAAAAGC AAGAATATCT TTGGTGGCCA TGTGTCTGGG 1740 ATGTGGGGTT CACCTATCAT CTGCCCCAGG GATCCTAAGA GGGGAACAGA TGGTGTTTTC 1800 AAAACCTATC TGGAAATTAA AAAGGTTACG GTGCTGAGAG GAAGAGCAGA GTCCAAGAGG 1860 AGGGGGCTGT GAGAGAGAAA CGCAGAGAGA 1890
|